Monitoring Agency Report for the quarter ended June 30, 2026

August 3, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Dear Sir/Ma’am, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report for the quarter ended June 30, 2026 issued by CARE Ratings Limited, Monitoring Agency, in respect of the utilization of the proceeds of the Preferential Issue. The aforesaid Monitoring Agency Report has been duly reviewed by the Audit Committee at its meeting held on August 3, 2026. The same is also available on the website of the Company at www.artemishospitals.com/investors. This is for your information and records. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary & Compliance Officer Encl.: As above No. CARE/NRO/GEN/2026-27/1081 The Board of Directors Artemis Medicare Services Limited Sector 51, Gurugram, 122001, Haryana August 03, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Preferential Issue of Artemis Medicare Services Limited (“the Company”) We write in our capacity of Monitoring Agency (MA) for the Preferential Issue for the amount aggregating to ₹330 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated April 03, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sandeep Aggarwal Associate Director sandeep.aggarwal@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Artemis Medicare Services Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Sandeep Aggarwal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Artemis Medicare Services Limited Name of the promoter : Mr. Onkar Kanwar and Constructive Finance Private Limited Industry/sector to which it belongs : Healthcare Services - Hospital 2) Issue Details Issue Period : Not Applicable Type of issue (public/rights) : Preferential Issue Type of specified securities : Compulsorily Convertible Debentures IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 330.00 CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Particulars Reply Source of information / Comments of the Comments of the certifications considered by Monitoring Agency Board of Directors Monitoring Agency for preparation of report Chartered Accountant The proceeds from the preferential issue No comments received Whether all utilization is as per the disclosures in the Offer certificate*, Management have been utilized as per the objectives Document? certificate, and Bank specified in the subscription agreement statement during the quarter ended June 30, 2026. Whether shareholder approval has been obtained in case of Chartered Accountant No comments received No material material deviations# from expenditures disclosed in the certificate*, Management Not applicable deviation Offer Document? certificate Chartered Accountant No comments received Whether the means of finance for the disclosed objects of No certificate*, Management Not applicable the issue have changed? certificate Chartered Accountant No comments received Is there any major deviation observed over the earlier No such deviation observed from the last No certificate*, Management monitoring agency reports? monitoring agency report. certificate As per management certificate, the proceeds No comments received are intended for an acquisition or capital Whether all Government/statutory approvals related to the Not applicable Management certificate expenditure. Based on the acquisition, any object(s) have been obtained? required approvals will be monitored at that point of time. As per management certificate, technical No comments received Whether all arrangements pertaining to technical Not applicable Management certificate assistance/ collaboration is not required as assistance/collaboration are in operation? per objects of the issue. Manag [Showing first 8,000 characters — download PDF for full document]